- Created by Riny Heijdendael, last modified by Former WMDA staff member on Feb 11, 2019
You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 9 Next »
Purpose |
The WMDA exists to achieve the best for stem cell donors and transplant patients, the strategy has been co-created with affiliate organisations so that it will support them to harness opportunities and mitigate risks in the medium-term. The strategy aims to deliver impact in the following areas:
In 2018, WMDA was funded a EU Third Health Programme. The 2018 project includes 13 Deliverables that were submitted to and approved by the European Commission. |
Projects |
---|
2018
Any questions/comments regarding these Deliverables can be addressed to esther.pustjens@wmda.info |
The EU Health Programme |
What is the Health Programme?The Health Programme is a funding instrument to support cooperation among EU countries and underpin and develop EU health activities. The legal basis for the Health Programme is agreed with the European Parliament and the Council for a period of several years. Third Health Programme (2014-2020)Regulation (EU) 282/2014 is the legal basis for the current Health Programme. With a budget of €449.4 million and throughout 23 priority areas, the Health Programme serves four specific objectives:
|
---|
Space AdministratorThe content of this macro is not accessible. Either you have not logged in or the people directory is disabled. Please log in or contact your administrator. |
Helpful Links
|
- No labels